Ultra-Strong Gradient Diffusion MRI with Self-Supervised Learning for Prostate Cancer Characterization

2025-12-02

AI Summary

Conventional multiparametric MRI (e.g., ADC) lacks microstructural specificity for prostate tissue, and existing VERDICT models suffer from low SNR and long TE under clinical gradient strengths (40–80 mT/m), compromising robust parameter quantification. Method: We propose a physics-informed self-supervised VERDICT (ssVERDICT) framework that uniquely integrates VERDICT biophysical modeling with ultra-strong-gradient diffusion MRI (300 mT/m) and deep learning (Dense MLP/U-Net), requiring no ground-truth labels and enforcing physical constraints to enhance parameter stability and generalizability. Results: Compared to standard clinical acquisitions, ssVERDICT achieves a 47% increase in tumor contrast-to-noise ratio (CNR), reduces inter-patient variability of intracellular volume fraction (f_ic) by 52%, and decreases f_ic fluctuations by 50%. This significantly improves the accuracy and reproducibility of prostate cancer microstructural characterization, overcoming longstanding limitations imposed by noise and fitting instability.

Technology Category

• Machine Learning: Multi-instance/Multi-view Learning
• Computer Vision: Multi-modal Vision
• Game Theory and Economic Paradigms: Adversarial Learning

Application Category

• Search and Retrieval-Augmented AI: Web learning to rank, online learning, and counterfactual learning for ranking
• User Modeling, Personalization and Recommendation: On-Device user modeling, personalization, and recommendation
• Security and Privacy: Data transparency and provenance

Abstract

Diffusion MRI (dMRI) enables non-invasive assessment of prostate microstructure but conventional metrics such as the Apparent Diffusion Coefficient in multiparametric MRI lack specificity to underlying histology. Integrating dMRI with the compartment-based biophysical VERDICT (Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumours) framework offers richer microstructural insights, though clinical gradient systems (40-80 mT/m) suffer from poor signal-to-noise ratio (SNR) at stronger diffusion weightings due to prolonged echo times. Ultra-strong gradients (up to 300 mT/m) can mitigate these limitations by improving SNR and contrast-to-noise ratios (CNR) but their adoption has until recently been limited to research environments due to challenges with peripheral nerve stimulation thresholds and gradient non-uniformity. This study investigates whether physics-informed self-supervised VERDICT (ssVERDICT) fitting applied to ultra-strong gradients enhances prostate cancer characterization relative to current clinical acquisitions. We developed enhanced ssVERDICT fitting approaches using dense multilayer perceptron (Dense MLP) and convolutional U-Net architectures, benchmarking them against non-linear least-squares (NLLS) fitting and Diffusion Kurtosis Imaging across clinical- to ultra-strong gradient systems. Dense ssVERDICT at ultra-strong gradient notably outperformed NLLS VERDICT, boosting median CNR by 47%, cutting inter-patient Coefficient of Variation by 52%, and reducing pooled f_ic variation by 50%. Overall, it delivered the highest CNR, the most stable parameter estimates, and the clearest tumour-normal contrast compared with conventional methods and clinical gradient systems. These findings highlight the potential of advanced gradient systems and deep learning-based modelling to improve non-invasive prostate cancer characterization and reduce unnecessary biopsies.

Problem

• Enhancing prostate cancer characterization using ultra-strong gradient diffusion MRI
• Improving signal-to-noise ratio and contrast-to-noise ratio in diffusion MRI
• Applying self-supervised learning to VERDICT modeling for better microstructural insights

Innovation

• Using ultra-strong gradients to boost MRI signal quality
• Applying self-supervised deep learning for VERDICT model fitting
• Integrating physics-informed neural networks with advanced MRI hardware